Sickle Cell Care Expansion Act of 2026
- Sponsor
- Sen. Van Hollen, Chris [D-MD]
- Committees
- Health, Education, Labor, and Pensions Committee (primary)
- Last action
- Sep 23, 2026
Bottom line
The bill seeks to expand the workforce, community support, and care coordination for sickle cell disease patients through federal funding and incentives.
What it actually does
This bill establishes three new programs under the Public Health Service Act aimed at improving care and research for sickle cell disease (SCD). It authorizes scholarships and loan repayments to incentivize physicians to specialize in SCD, provides grants for community-based education and advocacy programs, and funds initiatives to support SCD patients transitioning from pediatric to adult care.
Proponents argue
Supporters argue that the bill directly addresses critical shortages of physicians specializing in sickle cell disease, particularly for adult patients, and improves health outcomes by enhancing patient education, advocacy, and the often-challenging transition from pediatric to adult care. They contend that a comprehensive approach is necessary to tackle the disparities and complex needs associated with SCD.
Opponents contend
Critics might raise concerns about the overall cost of the authorized appropriations, questioning the long-term efficacy of federal scholarship and grant programs in sustainably solving healthcare workforce shortages or whether these programs might duplicate existing efforts. Some may also argue for alternative approaches to healthcare funding or workforce development.
The bill is concise and clearly structured, allowing for a thorough understanding within a reasonable timeframe.
Section 2, adding Subpart XIII, Section 340J to the Public Health Service Act
Sickle Cell Disease Physician Scholarship and Loan Repayment Program
This provision authorizes the Secretary of Health and Human Services to establish a program offering scholarships or loan repayments to individuals who agree to serve as physicians engaged in sickle cell disease research or treatment. Recipients must pursue a degree in medicine or osteopathic medicine, complete a residency consistent with a hematology fellowship, and then complete a hematology fellowship, serving one year for each year of scholarship received or for a period agreed upon for loan repayment.
Supporters argue
Supporters argue that this program is crucial for addressing the severe shortage of physicians specializing in sickle cell disease, particularly for adult patients, thereby improving access to expert care and advancing research efforts.
Critics contend
Critics might contend that while well-intentioned, such programs can be costly and may not always guarantee long-term retention of physicians in the targeted field once the service obligation is met, or that administrative overhead could reduce efficiency.
Tradeoffs
The program balances the need to attract talent to a critical medical specialty with the significant financial investment required. It also involves a tradeoff between broad medical training and highly specialized focus.
Section 2, adding Subpart XIII, Section 340J-1 to the Public Health Service Act
Community-Based Sickle Cell Disease Education and Advocacy Grants
This provision authorizes grants to eligible entities, such as community-based organizations, faith-based organizations, and Federally qualified health centers, to establish and support education and advocacy programs. These programs are designed to improve health literacy, disseminate information on health and community services, and enhance access to care and treatment decision-making for individuals with sickle cell disease and their families.
Section 2, adding Subpart XIII, Section 340J-2 to the Public Health Service Act
Sickle Cell Disease Transition of Care Grants
This provision authorizes grants to eligible nonprofit organizations, including hospitals and institutes of higher education, to establish programs supporting sickle cell disease patients aged 18-29 as they transition from pediatric to adult care. These programs must provide dedicated transition coordinators, assist with identifying adult providers, offer mental health services, and may include training for adult SCD care specialists through fellowships or short-term programs.
For both scholarship and loan repayment recipients, the bill mandates that individuals must complete a residency in a specialty consistent with pursuit of a fellowship in hematology, and then complete a fellowship in the specialty of hematology.
Sec. 340J(b)(2)(A)(ii)(IV)-(V) and (c)(2)(A)(ii)(IV)-(V)
Why it matters:This level of detail is standard legislative practice for defining eligibility and service obligations in federal programs, ensuring that the funds are directed towards highly specialized training relevant to the bill's purpose.
Case for: Proponents argue that this specificity ensures federal investment directly produces highly qualified hematologists specialized in sickle cell disease, maximizing the program's impact on patient care and research.
Case against: Critics might suggest that such rigid requirements could limit the pool of eligible applicants or exclude physicians who could contribute to SCD care through other, less direct, but still valuable specialties.
Estimated impact: Directs federal funding towards the creation of a highly specialized workforce, specifically hematologists, to address sickle cell disease.